glp 1 semaglutide dosage Microdosing GLP-1's for Weight Loss & Inflamation:-Dr Lipman, Miami Glucoregulatory Hormones | GLP-1/GIP Receptor

Vasilakou D, Karagiannis T, Athanasiadou E, et al

As new approved indications for GLP-1s continue to emerge, including uses related to cardiovascular disease and obstructive sleep apnea, more patients qualify for the medication

They are recommended for those who are overweight or obese and have not achieved optimal glycemic control despite intensive insulin therapy

[1] [2] The most commonly reported side effects in clinical trials were gastrointestinal, including nausea (occurring in 12-29% of patients), diarrhea, vomiting, constipation, and abdominal discomfort

On the other hand, the decreasing pattern of the hormone levels observed in both MO and PLC groups seems unrelated to dietary changes since no differences have been noted in nutrient intakes during the intervention in any of the groups (Table S4)